Oncogenic mutations or cancer-specific ABCA1 loss-of-function mutations decrease ABCA1 gene expression, which results in the compromise of ABCA1, enhancing the buildup of mitochondrial cholesterol and inhibiting the release of death-promoting molecules like cytochrome C, causing cancer cells to survive [48]. Here, CYCS is linked to cancer.